|
Tech Collective, Rhode Island’s bioscience and IT industry association, has announced the six winners of its inaugural Rhode Island Bioscience Awards.
more
By PBN Staff
|
|
When the Brown University researchers who formed BrainGate Co. enabled a paralyzed woman to operate a robotic arm through thought, scientists around the world heard about the breakthrough developed in Providence.
more
By Patrick Anderson |
|
Four months ago, when Denice Spero, co-director of
By Richard Asinof
Contributing Writer | 2/25/13 |
|
he Rhode Island Tech Collective announced last week that “science-centric” comedian Brian Malow is slated to perform at its inaugural Bioscience Awards celebration.
more
By Alex Kowalski |
|
Research spending at the University of Massachusetts in fiscal year 2012 surpassed the $500 million mark for the third consecutive year, UMass President Robert L. Caret announced Wednesday.
more
By PBN Staff
|
|
Dr. Jennifer Friedman, a pediatrician at Hasbro Children’s Hospital and director of clinical studies for the Center for International Health Research at Rhode Island, was awarded the 2012 Bruce M. Selya Award for excellence in research by Lifespan.
more
By Richard Asinof |
|
Medical technology maker Covidien PLC reported first-quarter earnings of $493 million, or $1.03 per diluted share, a slight decrease from the $494 million, or $1.02 per diluted share, reported for the first-quarter of its fiscal 2012.
more
By PBN Staff
|
|
Pharmaceutical developer Collegium Pharmaceutical Inc. has moved its operations out of Cumberland to more refined labs Canton, Mass., the company announced Thursday.
more
By Alex Kowalski |
|
On Wednesday evening, Stephen Lane - chairman, chief venture officer and co-founder of Ximedica - played host to a diverse group of more than 40 members of Rhode Island's emerging med-tech community to discuss strategies to enhance connectivity and collaboration.
more
By Richard Asinof |
|
Amgen Inc., one of the world’s biggest biotechnology companies, will spend as much as $180.5 million for the right to develop cancer drugs using nanotechnology from closely held Bind Biosciences.
more
By Elizabeth Lopatto |